Nervous System Diseases

 
Neurology, Rheumatology, and the Gut Microbiome: Two Specialists Discuss
July 16, 2021

A neurologist and a rheumatologist sat down with Patient Care editors to talk about their focus on balance in the gut microbiome as an essential element of clinical care.

FDA Awards Accelerated Approval to Aducanumab for Alzheimer Disease
June 07, 2021

The FDA approved today the first drug that targets the pathophysiolgic process responsible for Alzheimer disease and the first drug since 2003 to be approved for any Alzheimer treatment.

FDA Warns Lamotrigine May Cause Arrhythmias in Persons with Heart Disease
April 02, 2021

Healthcare providers are advised to weigh carefully the risks vs benefits of continuing lamotrigine therapy and not to substitute with another drug from the class.